Insiders Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
7.58 ^USD	-1.94%		-11.86%	-3.81%

Apr. 15	Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	CI
Apr. 15	Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Outlook Therapeutics, Inc. Announces Executive Changes	Dec. 06	CI
Outlook Therapeutics, Inc. Appoints Jedd Comiskey as Senior VP ? Head of Europe	Nov. 14	CI
Outlook Therapeutics, Inc. Announces Executive Appointments	23-01-19	CI
Outlook Therapeutics, Inc. Appoints Glen Olsheim as Executive Director, Commercial Excellence	23-01-19	CI
Insider Buy: Outlook Therapeutics	22-10-05	MT
Outlook Therapeutics, Inc. Announces Appointment of Julia A. Haller as Board of Director	22-08-15	CI
Outlook Therapeutics, Inc. Appoints Alicia Tozier as Senior Vice President of Marketing and Market Access	22-03-03	CI
Insider Buy: Outlook Therapeutics	22-02-23	MT
Outlook Therapeutics, Inc. Announces Appointment of Joel Prieve as Senior Vice President, Commercial Operations	22-02-08	CI
Insider Buy: Outlook Therapeutics	21-12-02	MT
Outlook Therapeutics, Inc. Announces CEO Changes	21-07-07	CI
Outlook Therapeutics, Inc. Announces Management Changes	21-07-07	CI
Outlook Therapeutics, Inc. Announces Board Appointments	20-11-19	CI
Outlook Therapeutics, Inc. Appoints Andong Huang as Director	20-06-23	CI
Outlook Therapeutics, Inc. Announces Board Changes	20-04-21	CI
Outlook Therapeutics, Inc. Announces Board and Committee Changes	19-12-19	CI
Outlook Therapeutics, Inc. Announces Resignation of Joerg Windisch as Member of Board of Director	19-07-24	CI
Pankaj Mohan Not to Stand for Re-Election to the Board of Directors of Outlook Therapeutics, Inc	19-06-28	CI
Outlook Therapeutics, Inc. Announces Termination of Kenneth M. Bahrt as Chief Medical Officer	19-04-26	CI
Outlook Therapeutics, Inc. Announces Executive Appointments	18-12-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Insiders

Filters